Perrigo Company plc (NYSE: PRGO), an Ireland-based global provider of Consumer Self-Care Products, announced on Wednesday that its board of directors has declared a quarterly dividend of USD0.290 per share, payable on September 16, 2025, to shareholders of record on August 29, 2025. This amount is unchanged from the previous quarterly dividend.
Perrigo Company plc is a pure-play self-care company with over a century of experience in providing health and wellness solutions to consumers, primarily in North America and Europe.
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement